Medium Development

Cell Culture Technology for Pharmaceutical and Cell-Based Therapies

Volumn , Issue , 2005, Pages 41-79

  Burgener, A ^a   Butler, M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85134914346     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780849351068-6     Document Type: Chapter

References (144)

1. Morgan JG, Morton HJ, Parker RC. Proc Soc Exp Biol Med 1950; 73:1-8.
2. Eagle H. Science 1955; 122:501.
3. Dulbecco R, Freeman G. Virology 1959; 8:396-397.
4. Ham R. Clonal growth of mammalian cells in a chemically defined synthetic medium. Proc Natl Acad Sci 1965; 53:288.
5. Moore GE, Gerner RE, Franklin HA. Culture of normal human leukocytes. J Am Acad Sci 1967; 199:519-524.
6. Eagle H. Science 1959; 130:432.
7. Stoker MGP, MacPherson I. Virology 1961; 14:359.
8. Stoker MGP, MacPherson I. Nature 1964; 203:1355.
9. MacPherson L, Stoker MGP. Virology 1962; 16:147.
10. Yamane I, Matsuya Y, Jimbo K. An autoclavable powdered culture medium for mammalian cells. Proc Soc Exp Biol Med 1968; 127:335-336.
11. Stanners CP, Eliceiri GL, Green H. Two types of ribosome in mouse-hamster hybrid cells. Nat New Biol 1971; 230:52-54.
12. McCoy TA, Maxwell M, Kruse PF. Proc Soc Exp Biol Med 1959; 100:115.
13. Hsu TC, Kellogg DS. J Natl Cancer Inst 1960; 25:221.
14. Iwakata S, Grace JT. NY State J Med 1964; 64:2279.
15. Morton HJ. A survey of commercially available tissue culture media. In Vitro 1970; 5:89-108.
16. Park MS, Terasaki PI. Transplantation 1974; 18:520.
17. Moore GE, Kitamura H. Cell line derived from patient with myeloma. NY State J Med 1968; 68:2054-2060.
18. Fischer GA. Ann NY Acad Sci 1958; 76:673.
19. Fischer GA, Sartorelli AS. Methods Med Res 1964; 10:247.
20. Leibovitz A. Am J Hyg 1963; 78:173.
21. Trowell OA. Exp Cell Res 1959; 16:118.
22. Williams GM, Gunn JM. Long-term cell culture of adult rat liver epithelial cells. Exp Cell Res 1974; 89:139-142.
23. Biggers JD, Gwatkin RBL, Heyner SJ. Exp Cell Res 1961; 25:41.
24. Parker RC. NY Acad Sci (spec publ) 1957; 5:303.
25. Morgan JF, Morton HJ, Parker RC. Proc Soc Exp Biol Med 1950; 73:1.
26. Murakami H. In: Mizrahi A, ed. Advances in Biotechnological Processes. Vol. 11. New York: A.R. Liss, 1989:107.
27. Barnes D, Sato G. Serum-free cell culture: a unifying approach. Cell 1980; 22:649-655.
28. Iscove NN, Melchers F. Complete replacement of serum by albumin, transferrin, and soybean lipid in cultures of lipopolysaccharide-reactive B lymphocytes. J Exp Med 1978; 147:923-933.
29. Bettger WJ, Boyce ST, Walthall BJ, Ham RG. Rapid clonal growth and serial passage of human diploid fibroblasts in a lipid-enriched synthetic medium supplemented with epidermal growth factor, insulin, and dexamethasone. Proc Natl Acad Sci USA 1981; 78:5588-5592.
30. Ryan PA, Maher VM, McCormick JJ. Modification of MCDB 110 medium to support prolonged growth and consistent high cloning efficiency of diploid human fibroblasts. Exp Cell Res 1987; 172:318-328.
31. Boyce ST, Ham RG. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol 1983; 81:33s-40s.
32. McKeehan WL, Hamilton WG, Ham RG. Selenium is an essential trace nutrient for growth of WI-38 diploid human fibroblasts. Proc Natl Acad Sci USA 1976; 73:2023-2027.
33. McKeehan WL, McKeehan KA, Hammond SL, Ham RG. Improved medium for clonal growth of human diploid fibroblasts at low concentrations of serum protein. In Vitro 1977; 13:399-416.
34. Morgan JF, Campbell ME, Morton HJ. Natl Cancer Inst 1955; 16:557.
35. Evans VJ, Bryant JC, Kerr HA, Schilling L. Exp Cell Res 1964; 36:439.
36. Evans VJ, Bryant JC, Fioramonti MC, McQuilkin WT, Sanford KK, Earle WR. Cancer Res 1956; 16:11.
37. Waymouth C. J Natl Cancer Inst 1959; 22:1003.
38. ISO. Water for Analytical Laboratory Use-Specification and Test Methods. International Organization for Standardization, 1987.
39. Neermann J, Wagner R. Comparative analysis of glucose and glutamine metabolism in transformed mammalian cell lines, insect and primary liver cells. J Cell Physiol 1996; 166:152-169.
40. Butler M, Christie A. Adaptation of mammalian cells to non-ammoniagenic media. Cytotechnology 1994; 15:87-94.
41. Butler M, Thilly WG. MDCK microcarrier cultured: seeding density effects and amino acid utilization. In Vitro 1982; 18:213-219.
42. Lambert K, Pirt SJ. The quantitative requirements of human diploid cells (strain MRC-5) for amino acids, vitamins and serum. J Cell Sci 1975; 17:397-411.
43. Roberts RS, Hsu HW, Lin KD, Yang TJ. Amino acid metabolism of myeloma cells in culture. J Cell Sci 1976; 21:609-615.
44. Arathoon WR, Telling RC. Uptake of amino acids and glucose by BHK 21 clone 13 suspension cells during cell growth. Dev Biol Stand 1981; 50:145-154.
45. Miller SWM, Blanch HW, Wilke CR. A kinetic analysis of hybridoma growth and metabolism in batch and continuous suspension culture: effect of nutrient concentration, dilution rate, and pH. Biotechnol Bioeng 2000; 67:853-871.
46. Linz M, Zeng AP, Wagner R, Deckwer WD. Stoichiometry, kinetics, and regulation of glucose and amino acid metabolism of a recombinant BHK cell line in batch and continuous cultures. Biotechnol Prog 1997; 13:453-463.
47. Holben DH, Smith AM. The diverse role of selenium within selenoproteins: a review. J Am Diet Assoc 1999; 99:836-843.
48. Mustacich D, Powis G. Thioredoxin reductase. Biochem J 2000; 346(Pt 1):1-8.
49. Seligman PA, Kovar J, Schleicher RB, Gelfand EW. Transferrin-independent iron uptake supports B lymphocyte growth. Blood 1991; 78:1526-1531.
50. Keenan J, Clynes M. Replacement of transferrin by simple iron compounds for MDCK cells grown and subcultured in serum-free medium. In Vitro Cell Dev Biol Anim 1996; 32:451-453.
51. Kan M, Yamane I. Effects of ferrous iron and transferrin on cell proliferation of human diploid fibroblasts in serum-free culture. In Vitro 1984; 20:89-94.
52. Wilmann M, Gautel M, Mayans O. Activation of calcium=calmodulin regulated kinases. Cell Mol Biol (Noisy-le-grand) 2000; 46:883-894.
53. Boisseau AM, Donatien P, Surleve-Bazeille JE, Amedee J, Harmand MF, Bezian JH, Maleville J, Taieb A. Production of epidermal sheets in a serum free culture system:a further appraisal of the role of extracellular calcium. J Dermatol Sci 1992; 3:111-120.
54. Daniels JT, Harris IR, Kearney JN, Ingham E. Calcium: a crucial consideration in serum-free keratinocyte culture. Exp Dermatol 1995; 4:183-191.
55. Praeger FC, Cristofalo VJ. The growth of WI-38 cells in a serum-free, growth factorfree, medium with elevated calcium concentrations. In Vitro Cell Dev Biol 1986; 22:355-359.
56. Peshwa MV, Kyung Y, McClure DB, Hu W. Cultivation of mammalian cells as aggregates in bioreactors: effect of calcium concentration on spatial distribution of viability. Biotechnol Bioeng 1993; 41:179-187.
57. Mobest D, Mertelsmann R, Henschler R. Serum-free ex vivo expansion of CD34 hematopoietic progenitor cells. Biotechnol Bioeng 1998; 60:341-347.
58. Bashir N, Kuhen K, Taub M. Phospholipids regulate growth and function of MDCK cells in hormonally defined serum free medium. In Vitro Cell Dev Biol 1992; 28A:663-668.
59. Carney D, Bunn P, Gazdar A, Pagan J, Minna J. Selective growth in serum-free hormone- supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung. Proc Natl Acad Sci USA 1981; 75:3185-3189.
60. Kim EJ, Kim NS, Lee GM. Development of a serum-free medium for the production of humanized antibody from Chinese hamster ovary cells using a statistical design. In Vitro Cell Dev Biol Anim 1998; 34:757-761.
61. Labitzke R, Friedl P. A serum-free medium formulation supporting growth of human umbilical cord vein endo-thelial cells in long-term cultivation. Cytotechnology 2001; 35:87-92.
62. Donatien P, Surleve-Bazeille JE, Thody AJ, Taieb A. Growth and differentiation of normal human melanocytes in a TPA-free, cholera toxin-free, low-serum medium and influence of keratinocytes. Arch Dermatol Res 1993; 285:385-392.
63. Hirobe T. Melanocyte stimulating hormone induces the differentiation of mouse epidermal melanocytes in serum-free culture. J Cell Physiol 1992; 152:337-345.
64. Furuya R, Akiu S, Naganuma M, Fukuda M, Hirobe T. The proliferation and differentiation of neonatal epidermal melanocytes in Fl hairless mice of HR-1 _HR=De in serum-free culture. J Dermatol 1998; 25:211-221.
65. Hedlund TE, Miller GJ. A serum-free defined medium capable of supporting growth of four established human prostatic carcinoma cell lines. Prostate 1994; 24:221-228.
66. Siegfried JM, Han YH, DeMichele MA, Hunt JD, Gaither AL, Cuttitta F. Production of gastrin-releasing peptide by a non-small cell lung carcinoma cell line adapted to serum-free and growth factor-free conditions. J Biol Chem 1994; 269:8596-8603.
67. Brower M, Carney DN, Oie HK, Gazdar AF, Minna JD. Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res 1986; 46:798-806.
68. Masuda N, Fukuoka M, Takada M, Kudoh S, Kusunoki Y. Establishment and characterization of 20 human non-small cell lung cancer cell lines in a serum-free defined medium (ACL-4). Chest 1991; 100:429-438.
69. Ruck A, Jakobson E, Bjorkman S, Paulie S. Adaptation of human bladder carcinoma cell lines to serum-free growth. Evidence for autocrine growth, stimulation. Anticancer Res 1994; 14:55-60.
70. Dartsch PC, Weiss HD, Betz E. Human vascular smooth muscle cells in culture: growth characteristics and protein pattern by use of serum-free media supplements. Eur J Cell Biol 1990; 51:285-294.
71. Merten OW. Safety issues of animal products used in serum-free media. Dev Biol Stand 1999; 99:167-180.
72. Tardieu M, Gamby C, Avramoglou T, Jozefonvicz J, Barritault D. Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF. J Cell Physiol 1992; 150:194-203.
73. Shiokawa K, Asano M, Shiozaki C. Function, molecular structure and gene expression of fibroblast growth factor (FGF=HBGF). Nippon Rinsho 1992; 50:1893-1901.
74. Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989; 58:575-606.
75. Jenkins N. Growth factors. In: Butler M, ed. Mammalian Cell Biotechnology. New York: Oxford University Press, 1991:39-55.
76. Gopas J, Ono M, Princler G, Smith MR, Tainsky MA, Siddiqui M, Wishniak O, Segal S, Kuwano M, Kung HF. EGF receptor activity and mitogenic response of Balb=3T3 cells expressing Ras and Myc oncogenes. EGF receptor activity in oncogene transformed cells. Cell Mol Biol 1992; 38:605-614.
77. Chua CC, Ladda RL. Protein kinase C and non-functional EGF receptor in K-ras transformed cells. Biochem Biophys Res Commun 1986; 135:435-444.
78. Haley JD. Regulation of epidermal growth factor receptor expression and activation: a brief review. Symp Soc Exp Biol 1990; 44:21-31.
79. Krane JF, Murphy DP, Carter DM, Krueger JG. Synergistic effects of epidermal growth factor (EGF) and insulin-like growth factor I=somatomedin C (IGF-I) on keratinocyte proliferation may be mediated by IGF-I transmodulation of the EGF receptor. J Invest Dermatol 1991; 96:419-424.
80. Simmons JG, Hoyt EC, Westwick JK, Brenner DA, Pucilowska JB, Lund PK. Insulinlike growth factor-I and epidermal growth factor interact to regulate growth and gene expression in IEC-6 intestinal epithelial cells. Mol Endocrinol 1995; 9:1157-1165.
81. Kaplan DR, Stephens RM. Neurotrophin signal transduction by the Trk receptor. J Neurobiol 1994; 25:1404-1417.
82. Yano H, Cong F, Birge RB, Goff SP, Chao MV. Association of the Abl tyrosine kinase with the Trk nerve growth factor receptor. J Neurosci Res 2000; 59:356-364.
83. Gangarosa LM, Dempsey PJ, Damstrup L, Barnard JA, Coffey RJ. Transforming growth factor-alpha. Baillieres Clin Gastroenterol 1996; 10:49-63.
84. Lawrence DA. Transforming growth factor-beta: a general review. Eur Cytokine Netw 1996; 7:363-374
85. Moses HL, Coffey RJ Jr, Leof EB, Lyons RM, Keski-Oja J. Transforming growth factor beta regulation of cell proliferation. Cell Physiol Suppl 1987 (suppl):1-7.
86. Barnes D, Sato G. Methods for growth of cultured cells in serum-free medium. Anal Biochem 1980; 102:255-270.
87. Williams LT. Signal transduction by the platelet-derived growth factor receptor. Science 1989; 243:1564-1570.
88. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 1989; 10:68-91.
89. Baxter RC. Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res 1994; 42:140-144.
90. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999; 79:1283-1316.
91. Taga T, Kishimoto T. Gpl30 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997; 15:797-819.
92. Kunioku H, Inoue K, Tomida M. Interleukin-6 protects rat PC 12 cells from serum deprivation or chemotherapeutic agents through the phosphatidylinositol 3-kinase and STAT3 pathways. Neurosci Lett 2001; 309:13-16.
93. Sterneck E, Kaplan DR, Johnson PF. Interleukin-6 induces expression of peripherin and cooperates with Trk receptor signaling to promote neuronal differentiation in PC12 cells. J Neurochem 1996; 67:1365-1374.
94. Sugasawara R. J Biotechnol 1988; 6:895.
95. Levy Y, Fermand JP, Brouet JC. Differential effects of low and high concentrations of interleukin 6 on human B cells. Eur J Immunol 1990; 20:2389-2393.
96. Wu YY, Bradshaw RA. Synergistic induction of neurite outgrowth by nerve growth factor or epidermal growth factor and interleukin-6 in PC 12 cells. J Biol Chem 1996; 271:13033-13039.
97. Glassy MC, Tharakan JP, Chau PC. Biotechnol Bioeng 1988; 32:1015.
98. Imagawa W, Bandyopadhyay GK, Wallace D, Nandi S. Phospholipids containing polyunsaturated fatty acyl groups are mitogenic for normal mouse mammary epithelial cells in serum-free primary cell culture. Proc Natl Acad Sci USA 1989; 86:4122-4126.
99. van Corven EJ, Groenink A, Jalink K, Eichholtz T, Moolenaar WH. Lysophosphatidate- induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell 1989; 59:45-54.
100. Murakami H, Masui H, Sato GH, Sueoka N, Chow TP, Kano-Sueoka T. Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component. Proc Natl Acad Sci USA 1982; 79:1158-1162.
101. Chen Z, Ke Y, Chen Y. A serum-free medium for hybridoma cell culture. Cytotechnology 1993; 1:169-174.
102. Sato JD, Kawamoto T, McClure DB, Sato GH. Cholesterol requirement of NS-1 mouse myeloma cells for growth in serum-free medium. Mol Biol Med 1984; 2:121-134.
103. Butler M, Huzel N. The effect of fatty acids on hybridoma cell growth and antibody productivity in serum-free cultures. J Biotechnol 1995; 39:165-173.
104. Butler M, Huzel N, Barnabe N. Unsaturated fatty acids enhance cell yields and perturb the energy metabolism of an antibody-secreting hybridoma. Biochem J 1997; 322:615-623.
105. Emerson TE Jr. Unique features of albumin: a brief review. Crit Care Med 1989; 77:690-694.
106. Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri CR, Loscalzo J. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 1992; 89:1614-1611.
107. Pollack S. Receptor-mediated iron uptake and intracellular iron transport. Am J Hematol 1992; 39:113-118.
108. Young SP, Garner C. Delivery of iron to human cells by bovine transferrin. Implications for the growth of human cells in vitro. Biochem J 1990; 265:587-591.
109. Kleinman HK, Luckenbill-Edds L, Cannon FW, Sephel GC. Use of extracellular matrix components for cell culture. Anal Biochem 1987; 166:1-13.
110. Orly J, Sato G. Fibronectin mediates cytokinesis and growth of rat follicular cells in serum-free medium. Cell 1979; 17:295-305.
111. Ilic D, Almeida EA, Schlaepfer DD, Dazin P, Aizawa S, Damsky CH. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J Cell Biol 1998; 143:547-560.
112. Danen EH, Sonneveld P, Sonnenberg A, Yamada KM. Dual stimulation of Ras= mitogen-activated protein kinase and RhoA by cell adhesion to fibronectin supports growth factor-stimulated cell cycle progression. Cell Biol 2000; 151:1413-1422.
113. Hotchin NA, Kidd AG, Altroff H, Mardon HJ. Differential activation of focal adhesion kinase, Rho and Rac by the ninth and tenth FIII domains of fibronectin. J Cell Sci 1999; 112:2937-2946.
114. von der Mark K, Kuhl U. Laminin and its receptor. Biochim Biophys Acta 1985; 823:147-160.
115. Kam L, Shain W, Turner JN, Bizios R. Axonal outgrowth of hippocampal neurons on micro-scale networks of polylysine-conjugated laminin. Biomaterials 2001; 22:1049-1054.
116. Varani J, Inman DR, Frigid SE, Hillegas WJ. Use of recombinant and synthetic peptides as attachment factors for cells on microcarriers. Cytotechnology 1993; 13:89-98.
117. Esty A. Receptor-specific serum-free cell attachment using a highly stable engineered protein polymer. Am Biotechnol Lab 1991; 9:44.
118. Kovar J. Growth-stimulating effect of ferric citrate on hybridoma cells: characterization and relation to transferrin function. Hybridoma 1988; 7:255-263.
119. MacLeod AJ. In: Butler M, ed. Mammalian Cell Biotechnology: A Practical Approach. Oxford: Oxford University Press, 1991:28-38.
120. Schlaeger EJ. The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promoter of mammalian cell culture in serum-containing and serum-free media and displays anti-apoptosis properties. J Immunol Methods 1996; 194:191-199.
121. Kistner O, Barrett PN, Mundt W, Reiter M, Schober-Bendixen S, Eder G, Dorner F. A novel mammalian cell (vero) derived influenza virus vaccine: development, characterization and industrial scale production. Wien Klin Wochenschr 1999; 111:207-214.
122. Majoul S, Kharmachi H, Saadi M, Chouaib A, Kallel H. Adaption of vero cells to a serum-free medium for the production of rabies virus. In: Bernard A, et al, eds. Animal Cell Technology: Products from Cells, Cells as Products. Dordrecht: Kluwer Academic Publishers, 1999:467-469.
123. Montagnon BJ, Vincent-Falquet JC, Saluzzo JF. Experience with vero cells at Pasteur Merieux Connaught. Dev Biol Stand 1999; 98:137-140.
124. Voeten JT, Brands R, Palache AM, van Scharrenburg GJ, Rimmelzwaan GF, Osterhaus AD, Claas EC. Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium. Vaccine 1999; 17:1942-1950.
125. Perrin P, Madhusudana S, Gontier-Jallet C, Petres S, Tordo N, Merten OW. An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system. Vaccine 1995; 13:1244-1250.
126. Yahi N, Baghdiguian S, Fantini J. Production of a highly cytopathic HIV-1 isolate from a human mucosal epithelial cell line cultured on microcarrier beads in serum-free medium. In Vitro Cell Dev Biol Anim 1995; 31:62-66.
127. Gardner TA, Ko SC, Yang L, Cadwell JJ, Chung LW, Kao C. Serum-free recombinant production of adenovirus using a hollow fiber capillary system. Biotechniques 2001; 30:422-427.
128. Butler M, Burgener A, Patrick M, Berry M, Moffatt D, Huzel N, Barnabe N, Coombs K. Application of a serum-free medium for the growth of vsero cells and the production of reovirus. Biotechnol Prog 2000; 16:854-858.
129. Ryll T, Lucki-Lange M, Jager V, Wagner R. Production of recombinant human interleukin-2 with BHK cells in a hollow fibre and a stirred tank reactor with protein-free medium. J Biotechnol 1990; 14:377-392.
130. Valyakina TI, Vershinina NV, Gilyarevskii SD, Nesmeyanov VA. Production of interleukin 2 in serum-free medium. Mol Immunol 1984; 21:811-814.
131. Castro PM, Hayter P, Ison AP, Bull AT. Application of a statistical design to the optimization of culture medium for recombinant interferon-gamma production by Chinese hamster ovary cells. Appl Microbiol Biotechnol 1992; 55:84-90.
132. Miyaji H, Harada N, Mizukami T, Sato S, Fujiyoshi N, Itoh S. Efficient expression of human beta-interferon in Namalwa KJM-1 cells adapted to serum-free medium by a dhfr gene coamplification method. Cytotechnology 1990; 4:173-180.
133. Kim YN, Park YS, Kim HK, Jeon BC, Youn SE, Lee HY. Enhancement of the attachment on microcarriers and tPA production by fibroblast cells in a serum-free medium by the addition of the extracts of Centella asiatica. Cytotechnology 1993; 13:221-226.
134. Haldankar R, Kopchick JJ, Ridgway D. Stable production of a human growth hormone antagonist from CHO cells adapted to serum-free suspension culture. Biotechnol Prog 1999; 15:336-346.
135. Boedeker D. Production processes of licensed recombinant factor VIII preparations. Semin Thromb Hemost 2001; 27:385-394.
136. Stoll TS, Muhlethaler K, von Stockar U, Marison IW. Systematic improvement of a chemically-defined protein-free medium for hybridoma growth and monoclonal antibody production. J Biotechnol 1996; 45:111-123.
137. Voigt A, Zintl F. Hybridoma cell growth and anti-neuroblastoma monoclonal antibody production in spinner flasks using a protein-free medium with microcarriers. J Biotechnol 1999; 68:213-226.
138. Inoue Y, Lopez LB, Kawamoto S, Arita N, Teruya K, Seki K, Shoji M, Kamei M, Hashizume S, Shiozawa Y, Tachibana H, Ohashi H, Yasumoto K, Nagashima A, Nakahashi H, Suzuki T, Imai T, Nomoto K, Takenoyama M, Katakura Y, Shirahata S. Production of recombinant human monoclonal antibody using ras-amplified BHK-21 cells in a protein-free medium. Biosci Biotechnol Biochem 1996; 60:811-817.
139. Cinatl J Jr, Cinatl J, Rabenau H, Ebener U, Kornhuber B, Doerr HW. Increased HIV-1 production in chronically infected H9 cells grown in protein-free medium. Arch Virol 1992; 125:327-330.
140. Pinter C, Siccardi AG, Clivio A. Production of human immunodeficiency virus by chronically infected cells grown in protein-free medium. Cell Biol Int 1995; 19:507-515.
141. Ham RG. In: Fischer G, Wieser RJ, eds. Hormonally Defined Media. Berlin: Springer-Verlag, 1983:16-30.
142. Davis GE, Skaper SD, Manthorpe M, Moonen G, Varon S. Fetal calf serum-mediated inhibition of neurite growth from ciliary ganglion neurons in vitro. J Neurosci Res 1984; 12:29-39.
143. Lee GM, Kim EJ, Kim NS, Yoon SK, Ahn YH, Song JY. Development of a serum-free medium for the production of erythropoietin by suspension culture of recombinant Chinese hamster ovary cells using a statistical design. J Biotechnol 1999; 69:85-93.
144. Causey AL, Wooten RM, Clem LW, Bly JE. A serum-free medium for human primary T. lymphocyte culture. J Immunol Methods 1994; 175(1):115-121.